Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
P-IL-2
i
Other names:
P-IL-2, Platelet-coupled IL-2 Cell Injection
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Zcapsule
Drug class:
IL-2 stimulant
Related drugs:
‹
denileukin diftitox (4)
CUE-101 (3)
NKTR-214 (3)
aldesleukin (2)
AVB-001 (1)
denileukin diftitox-cxdl (1)
AB248 (0)
AGX-148 (0)
ALT-801 (0)
AWT020 (0)
BNT151 (0)
CLN-617 (0)
CUE-102 (0)
CUG288 (0)
celmoleukin (0)
DI Leu16 IL-2 (0)
GS-4528 (0)
HM16390 (0)
teceleukin (0)
KY1043 (0)
LOAd732 (0)
MDNA11 (0)
leukocyte interleukin injection (0)
NL-201 (0)
ODC-IL2 (0)
PF-06753512 (0)
PSA/IL-2/GM-CSF vaccine (0)
SHR-1916 (0)
STK-009/SYNCAR-001 (0)
attenuated Salmonella typhimurium expressing IL-2 (0)
EMD 521873 (0)
IL2-L19-TNF (0)
WTX-124 (0)
Ax-101 (0)
RG7813 (0)
L19IL2 (0)
RG6279 (0)
TILT-123 (0)
AU-007 (0)
STAR-LLD SC (0)
APN301 (0)
TG4010 (0)
SOT101 (0)
SAR444245 (0)
RG7461 (0)
F16-IL2 (0)
TG4001 (0)
denileukin diftitox (4)
CUE-101 (3)
NKTR-214 (3)
aldesleukin (2)
AVB-001 (1)
denileukin diftitox-cxdl (1)
AB248 (0)
AGX-148 (0)
ALT-801 (0)
AWT020 (0)
BNT151 (0)
CLN-617 (0)
CUE-102 (0)
CUG288 (0)
celmoleukin (0)
DI Leu16 IL-2 (0)
GS-4528 (0)
HM16390 (0)
teceleukin (0)
KY1043 (0)
LOAd732 (0)
MDNA11 (0)
leukocyte interleukin injection (0)
NL-201 (0)
ODC-IL2 (0)
PF-06753512 (0)
PSA/IL-2/GM-CSF vaccine (0)
SHR-1916 (0)
STK-009/SYNCAR-001 (0)
attenuated Salmonella typhimurium expressing IL-2 (0)
EMD 521873 (0)
IL2-L19-TNF (0)
WTX-124 (0)
Ax-101 (0)
RG7813 (0)
L19IL2 (0)
RG6279 (0)
TILT-123 (0)
AU-007 (0)
STAR-LLD SC (0)
APN301 (0)
TG4010 (0)
SOT101 (0)
SAR444245 (0)
RG7461 (0)
F16-IL2 (0)
TG4001 (0)
›
Associations
News
Trials
Filter by
Latest
10ms
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 (clinicaltrials.gov)
P1, N=10, Recruiting, Zhejiang University | Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2023 --> Dec 2024
10 months ago
Enrollment open • Trial primary completion date • Metastases
|
P-IL-2
over1year
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 (clinicaltrials.gov)
P1, N=10, Not yet recruiting, Zhejiang University
over 1 year ago
New P1 trial • Metastases
|
IL10 (Interleukin 10)
|
P-IL-2
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login